APA (7th ed.) Citation

S, W., Q, Y., L, D., Q, L., Y, Y., P, M., . . . N, L. (2022). An overview of cancer drugs approved through expedited approval programs and orphan medicine designation globally between 2011 and 2020. Drug discovery today, 27(5), 1236. https://doi.org/10.1016/j.drudis.2021.12.021

Chicago Style (17th ed.) Citation

S, Wang, et al. "An Overview of Cancer Drugs Approved Through Expedited Approval Programs and Orphan Medicine Designation Globally Between 2011 and 2020." Drug Discovery Today 27, no. 5 (2022): 1236. https://doi.org/10.1016/j.drudis.2021.12.021.

MLA (9th ed.) Citation

S, Wang, et al. "An Overview of Cancer Drugs Approved Through Expedited Approval Programs and Orphan Medicine Designation Globally Between 2011 and 2020." Drug Discovery Today, vol. 27, no. 5, 2022, p. 1236, https://doi.org/10.1016/j.drudis.2021.12.021.